UEG Week Recordings UEG Week Posters Online courses Guidelines Mistakes in... Podcasts Webinars
new
Gut Guide online
Visit ueg.eu Create myUEG account Log In
Visit ueg.eu Create myUEG account Log In

Filters:

UEG Online Course
accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Endoscopic retrograde cholangiopancreatography (ERCP)

Bharat Paranandi, Matthew Huggett, Fahd Rana

Summary

AI Generated

An online educational course provides expert guidance on level 1–2 ERCP procedures for beginners in the early stages of ERCP training.

  • The course covers how to approach level 1–2 ERCPs, which are the least difficult and complex procedures.
  • Content includes scope design, indications and contraindications, ERCP categories, patient information and consent, sedation, the ERCP technique, complications, and post-ERCP care.
  • Learning objectives focus on understanding communication and consent, basic ERCP skills, different ERCP categories, and awareness of indications, contraindications, and complications.
  • The course was reviewed and updated in April 2024 and is taught by Fahd Rana, Bharat Paranandi, and Matthew Huggett.
Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Overview

Endoscopic retrograde cholangiopancreatography (ERCP) is a technique that combines the use of endoscopy and fluoroscopy for the treatment of benign or malignant pathologies related to the biliary or pancreatic ductal systems. ERCP is a challenging and important therapeutic procedure that requires life-long learning and the need to adapt to the therapeutic aims on a case-by-case basis.

In this online course, Fahd Rana, Bharat Paranandi and Matthew Huggett provide expert guidance on how to approach level 1–2 ERCPs, which are the least difficult/complex procedures. They cover scope design, indications and contraindications for ERCP, different ERCP categories, patient information and consent, sedation, the ERCP technique itself, complications and post-ERCP care.

Learning objectives

  • To understand the importance of communication, patient information and consent
  • To be aware of the indications and contraindications for ERCP
  • To understand the basic skills involved in ERCP
  • To understand the different categories of ERCP
  • To be aware of the complications of ERCP

Target audience

This course is aimed at beginners in ERCP who are in the early stages of ERCP training.

Reviewed & updated April 2024

Event

Endoscopic retrograde cholangiopancreatography (ERCP)

Topics

Endoscopy Hepatobiliary

Accreditation status

accredited

Duration

1 hour

Published

2019

More Like This:

COMPLICATIONS OF THE FIRST ENDOSONOGRAPHY-GUIDED DRAINAGE VS. FOLLOWING INTERVENTIONS IN PANCREATIC FLUID COLLECTIONS AND NECROSIS

COMPLICATIONS OF THE FIRST ENDOSONOGRAPHY-GUIDED DRAINAGE VS. FOLLOWING INTERVENTIONS IN PANCREATIC FLUID COLLECTIONS AND NECROSIS

Federica Branchi Federica Branchi, Alexander Wree, Frank Tacke, Juliane Buchkremer, Andreas Adler, Theresa Maria Holtmann, Özlem Celebi, Felix Johannes Körner, Christos Makris, Michael Sigal, Christian Jürgensen, Marcel Razpotnik

EX VIVO EFFECTS OF INFLIXIMAB ON THE LONG NON-CODING RNAS EXPRESSION LEVELS IN CROHN´S DISEASE

EX VIVO EFFECTS OF INFLIXIMAB ON THE LONG NON-CODING RNAS EXPRESSION LEVELS IN CROHN´S DISEASE

Jose Andres Moreno-Monteagudo Jose Andres Moreno-Monteagudo, Javier P. Gisbert, María Chaparro, David Bernardo, Ana M. Aransay, Urko M. Marigorta, Irene Becerro Gonzalez, Sergio Casabona-Francés, Fernando Casals Seoane, María José Casanova, Cecilio Santander Vaquero, Paloma Fernández, Ricardo Arroyo, Cristina Ramírez, Irene Soleto, Samuel Fernández-Tomé, Lorena Ortega Moreno, Macarena Orejudo del Río, Cristina Rubín de Célix, Montse Baldan Martin

EUROPEAN AND UNITED STATES PATIENT PERSPECTIVES ON THE IMPACT OF MODERATE TO SEVERE ULCERATIVE COLITIS ON SEXUAL ACTIVITY: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

EUROPEAN AND UNITED STATES PATIENT PERSPECTIVES ON THE IMPACT OF MODERATE TO SEVERE ULCERATIVE COLITIS ON SEXUAL ACTIVITY: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

Simon Travis Simon Travis, Eoin J. Flynn, Christian Atkinson, David T. Rubin, Stefan Schreiber, Christophe Sapin, Theresa Hunter Gibble, Cem Kayhan, Toshifumi Hibi, Remo Panaccione, Marla C. Dubinsky, Alison Potts Bleakman

NOVEL CATHETER DEDICATED FOR ENDOSCOPIC TRANSMURAL NECROSECTOMY OF PANCREATIC WALLED-OFF NECROSIS: EXPERIENCES FROM A TERTIARY REFERRAL CENTER

NOVEL CATHETER DEDICATED FOR ENDOSCOPIC TRANSMURAL NECROSECTOMY OF PANCREATIC WALLED-OFF NECROSIS: EXPERIENCES FROM A TERTIARY REFERRAL CENTER

John Gásdal Karstensen John Gásdal Karstensen, Palle Nordblad Schmidt, Erik Feldager, Srdan Novovic, Gitte Aabye Olsen

ESGE highlights with Ian Gralnek

ESGE highlights with Ian Gralnek

Ian Mark Gralnek Ian Mark Gralnek, Egle Dieninyte - Misiune

Advanced ERCP - Part 1

Advanced ERCP - Part 1

Simon Phillpotts Simon Phillpotts, George Webster, Gavin Johnson

UEG Poster
Standard Poster
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

COMPLICATIONS OF THE FIRST ENDOSONOGRAPHY-GUIDED DRAINAGE VS. FOLLOWING INTERVENTIONS IN PANCREATIC FLUID COLLECTIONS AND NECROSIS

Marcel Razpotnik 1, Christian Jürgensen 1, Michael Sigal 1, Christos Makris 1, Felix Johannes Körner 1, Özlem Celebi 1, Theresa Maria Holtmann 1, Andreas Adler 1, Federica Branchi 1, Juliane Buchkremer 1, Frank Tacke 1, Alexander Wree 1

Affiliations

1 Charité - Universitätsmedizin Berlin, Berlin, Germany

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Introduction

In general, it is recognized that there is a considerable risk of complications following early endotherapy in the development of pancreatic fluid collections. However, there is still limited information regarding the optimal timing for endosonography (EUS)-guided drainage once a well-defined wall has formed and the relative risk of complications in subsequent interventions.

Aims & Methods

Our study aims to examine the risk of the first EUS-guided drainage compared to the following interventions in pancreatic fluid collections and necrosis. Data on EUS-guided drainage of pancreatic fluid collections performed between 2018 and 2022 at three endoscopy units of Charité- Berlin, regardless of the etiology, were reviewed and analyzed. Adverse events were defined and graded according to the recommendations of the American Society of Gastrointestinal Endoscopy1. A severe event following an endoscopic procedure is defined as one that necessitates unplanned admission, prolongs hospital stay by > 10 nights, requires ICU admission for > 1 night, or results in surgery or permanent disability. The Cox proportional hazards regression model was used to examine the relationship between the timing of EUS-guided therapy and the occurrence of complications, adjusting for patient- and procedure-related (age, gender, body-mass index, comorbidities, etiology, size) covariates.

Results

In a cohort of 102 patients (72.5% male, mean age 57.0 ± 14.1 years), 202 procedures were performed, of which 71 (35.1%) were necrosectomies. The predominant etiology was fluid collection complicating pancreatic resection (31.4%), followed by alcohol-induced (22.5%) and biliary (18.6%) pancreatitis. Nearly half of the cases presented with necrotic particles on pre-interventional imaging and 85.3% had a fully definable wall. Adverse events were observed in 24 of the 202 (11.9%) procedures. Six were classified as severe and predominantly occurred during the initial session. The most frequently reported adverse event was bleeding (4.5%), followed by abdominal pain (1.9%), infection (1.9%), and perforation (0.9%). Three patients died within 30 days after the intervention and were indirectly associated with iatrogenic-induced infection of previously sterile collection. In the Cox proportional hazards regression analysis, which was adjusted for confounding variables, the first intervention emerged as a significant predictor of complications, with a hazard ratio (HR) of 3.5 (95% CI 1.2-10.7). This finding suggests an increased risk of complications during the initial endotherapy session for pancreatic fluid collections. Conversely, there was an association between the post-pancreatitis fluid collections and complications with an HR of 3.1 (95% CI 0.7- 14.0) compared to post-surgery collections but it did not reach statistical significance. The procedure's duration and the collection size were not associated with the risk of complications.

1. Intervention2. Intervention3. Intervention4. Intervention
Numbern=102n=53n=26n=21
Time after symptoms (days)32.1 ± 24.044.6 ± 24.746.6 ± 26.250.3 ± 20.6
Time of the procedure (min)36.9 ± 16.346.9 ± 28.360.8 ± 26.764.6 ± 30.9
Necrosectomy (%)5 (4.9%)32 (60.4%)18 (69.2%)16 (76.2%)
Complications (%)14 (13.7%)5 (9.4%)2 (7.7%)3 (14.3%)
Complication severity
Mild
Moderate
Severe
7 (6.9%)
3 (2.9%)
4 (3.9%)
3 (5.7%)
1 (1.9%)
1 (1.9%)
2 (7.7%)
0
0
1 (4.8%)
1 (4.8%)
1 (4.8%)

Conclusion

In the EUS-guided therapy of pancreatic fluid collections, the initial intervention emerged as a significant predictor of complications. While post-pancreatitis collections tend toward a higher complication rate compared to post-surgical collections, early intervention strategies require careful consideration to reduce risks.

References

1. Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010 Mar;71(3):446-54.

Conference

UEG Week Vienna 2024

Topics

Pancreas

Submission format

Abstract

Session

Pancreatic endoscopy (Posters)

Citation

United European Gastroenterology Journal 2024; 12 (Supplement 8)

Published

2024

More Like This:

COMPLICATIONS OF THE FIRST ENDOSONOGRAPHY-GUIDED DRAINAGE VS. FOLLOWING INTERVENTIONS IN PANCREATIC FLUID COLLECTIONS AND NECROSIS

COMPLICATIONS OF THE FIRST ENDOSONOGRAPHY-GUIDED DRAINAGE VS. FOLLOWING INTERVENTIONS IN PANCREATIC FLUID COLLECTIONS AND NECROSIS

Federica Branchi Federica Branchi, Alexander Wree, Frank Tacke, Juliane Buchkremer, Andreas Adler, Theresa Maria Holtmann, Özlem Celebi, Felix Johannes Körner, Christos Makris, Michael Sigal, Christian Jürgensen, Marcel Razpotnik

EX VIVO EFFECTS OF INFLIXIMAB ON THE LONG NON-CODING RNAS EXPRESSION LEVELS IN CROHN´S DISEASE

EX VIVO EFFECTS OF INFLIXIMAB ON THE LONG NON-CODING RNAS EXPRESSION LEVELS IN CROHN´S DISEASE

Jose Andres Moreno-Monteagudo Jose Andres Moreno-Monteagudo, Javier P. Gisbert, María Chaparro, David Bernardo, Ana M. Aransay, Urko M. Marigorta, Irene Becerro Gonzalez, Sergio Casabona-Francés, Fernando Casals Seoane, María José Casanova, Cecilio Santander Vaquero, Paloma Fernández, Ricardo Arroyo, Cristina Ramírez, Irene Soleto, Samuel Fernández-Tomé, Lorena Ortega Moreno, Macarena Orejudo del Río, Cristina Rubín de Célix, Montse Baldan Martin

EUROPEAN AND UNITED STATES PATIENT PERSPECTIVES ON THE IMPACT OF MODERATE TO SEVERE ULCERATIVE COLITIS ON SEXUAL ACTIVITY: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

EUROPEAN AND UNITED STATES PATIENT PERSPECTIVES ON THE IMPACT OF MODERATE TO SEVERE ULCERATIVE COLITIS ON SEXUAL ACTIVITY: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

Simon Travis Simon Travis, Eoin J. Flynn, Christian Atkinson, David T. Rubin, Stefan Schreiber, Christophe Sapin, Theresa Hunter Gibble, Cem Kayhan, Toshifumi Hibi, Remo Panaccione, Marla C. Dubinsky, Alison Potts Bleakman

NOVEL CATHETER DEDICATED FOR ENDOSCOPIC TRANSMURAL NECROSECTOMY OF PANCREATIC WALLED-OFF NECROSIS: EXPERIENCES FROM A TERTIARY REFERRAL CENTER

NOVEL CATHETER DEDICATED FOR ENDOSCOPIC TRANSMURAL NECROSECTOMY OF PANCREATIC WALLED-OFF NECROSIS: EXPERIENCES FROM A TERTIARY REFERRAL CENTER

John Gásdal Karstensen John Gásdal Karstensen, Palle Nordblad Schmidt, Erik Feldager, Srdan Novovic, Gitte Aabye Olsen

ESGE highlights with Ian Gralnek

ESGE highlights with Ian Gralnek

Ian Mark Gralnek Ian Mark Gralnek, Egle Dieninyte - Misiune

Advanced ERCP - Part 1

Advanced ERCP - Part 1

Simon Phillpotts Simon Phillpotts, George Webster, Gavin Johnson

UEG Poster
Standard Poster
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

EX VIVO EFFECTS OF INFLIXIMAB ON THE LONG NON-CODING RNAS EXPRESSION LEVELS IN CROHN´S DISEASE

Montse Baldan Martin 1, Cristina Rubín de Célix 1, Macarena Orejudo del Río 1, Lorena Ortega Moreno 2, Samuel Fernández-Tomé 1,3, Irene Soleto 1, Cristina Ramírez 1, Ricardo Arroyo 4, Paloma Fernández 4, Cecilio Santander Vaquero 1, Jose Andres Moreno-Monteagudo 1, María José Casanova 1, Fernando Casals Seoane 1, Sergio Casabona-Francés 1, Irene Becerro Gonzalez 1, Urko M. Marigorta 5, Ana M. Aransay 6, David Bernardo 7, María Chaparro 1, Javier P. Gisbert 1

Affiliations

1 Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain

2 Área de Farmacología y Nutrición y Bromatología, Universidad Rey Juan Carlos, Madrid, Spain

3 Facu

4 Instituto de Medicina Molecular Aplicada Nemesio Díez (IMMA-ND), Facultad de Medicina. Universidad San Pablo CEU, Madrid, Spain

5 Integrative Genomics Lab, CIC bioGUNE-BRTA and IKERBASQUE, Basque Foundation for Science, Bilbao, Spain

6 Genome Analysis Platform, CIC bioGUNE-BRTA and CIBERehd, Bilbao, Spain

7 Mucosal Immunology Lab, Unidad de Excelencia Instituto de Biomedicina y Genética Molecular (IGBM, Universidad de Valladolid-CSIC) and Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Valladolid, Spain

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Introduction

In recent years, evidence shows that long non-coding RNAs (lncRNAs) are key regulators of gene transcription and play important roles in the pathogenesis of inflammatory bowel diseases. LncRNAs are involved in the regulation of intestinal epithelial cell apoptosis, cell-cell interactions, and enhancing inflammation, among others. Biological therapies, which are considered the most potent for disease control, only benefit one-third of patients. For this reason, a deeper understanding of the mechanisms by which biological drugs elicit their effect on intestinal mucosal is needed. Hence, we aimed to unravel the ex vivo modulator effect of infliximab on the lncRNAs expression in intestinal biopsies from patients with Crohn´s Disease (CD).

Aims & Methods

We performed an unbiased transcriptomic analysis of intestinal biopsies from the ileum and colon from 30 patients [active CD = 10, quiescent CD = 10, healthy controls (HC) = 10] to identify lncRNA differentially expressed in the setting of infliximab modulation. Endoscopic biopsies were cultured with or without infliximab and the transcriptome was determined by Illumina gene expression array. We used different databases (Ensembl Biomart, RNAcentral and ToppGene) to search for non-annotated lncRNA information and data on the location (cellular component), biological process and molecular function of differentially expressed lncRNAs.

Results

Transcriptomic results revealed a widespread dysregulation of lncRNAs in ileum biopsies from patients with active CD, quiescent CD and HC compared to the colon at baseline and after infliximab culture. These differentially expressed lncRNAs were enriched in such pathways as proliferation, apoptosis, migration, inflammatory response of fibroblasts, response to wounding, posttranscriptional regulation of inflammatory genes and activation of the mitogen-activated protein kinase signaling pathways. Regarding the effect of infliximab according to intestinal location, presence of disease and activity, no significant lncRNAs were identified in the different study comparatives.

Conclusion

We have characterized the basal transcriptomic landscape of lncRNAs in patients with CD (active and quiescent) and HC both in ileum and left colon. However, we have not found differential lncRNA expression due to the effect of infliximab, suggesting that the location (ileum or colon) is more relevant when analyzing differences in lncRNA expression in the intestinal tissue.

Conference

UEG Week Copenhagen 2023

Topics

IBD

Submission format

Abstract

Session

PP 05 IBD (Posters)

Citation

United European Gastroenterology Journal 2023; 11 (Supplement 8)

Published

2023

More Like This:

COMPLICATIONS OF THE FIRST ENDOSONOGRAPHY-GUIDED DRAINAGE VS. FOLLOWING INTERVENTIONS IN PANCREATIC FLUID COLLECTIONS AND NECROSIS

COMPLICATIONS OF THE FIRST ENDOSONOGRAPHY-GUIDED DRAINAGE VS. FOLLOWING INTERVENTIONS IN PANCREATIC FLUID COLLECTIONS AND NECROSIS

Federica Branchi Federica Branchi, Alexander Wree, Frank Tacke, Juliane Buchkremer, Andreas Adler, Theresa Maria Holtmann, Özlem Celebi, Felix Johannes Körner, Christos Makris, Michael Sigal, Christian Jürgensen, Marcel Razpotnik

EX VIVO EFFECTS OF INFLIXIMAB ON THE LONG NON-CODING RNAS EXPRESSION LEVELS IN CROHN´S DISEASE

EX VIVO EFFECTS OF INFLIXIMAB ON THE LONG NON-CODING RNAS EXPRESSION LEVELS IN CROHN´S DISEASE

Jose Andres Moreno-Monteagudo Jose Andres Moreno-Monteagudo, Javier P. Gisbert, María Chaparro, David Bernardo, Ana M. Aransay, Urko M. Marigorta, Irene Becerro Gonzalez, Sergio Casabona-Francés, Fernando Casals Seoane, María José Casanova, Cecilio Santander Vaquero, Paloma Fernández, Ricardo Arroyo, Cristina Ramírez, Irene Soleto, Samuel Fernández-Tomé, Lorena Ortega Moreno, Macarena Orejudo del Río, Cristina Rubín de Célix, Montse Baldan Martin

EUROPEAN AND UNITED STATES PATIENT PERSPECTIVES ON THE IMPACT OF MODERATE TO SEVERE ULCERATIVE COLITIS ON SEXUAL ACTIVITY: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

EUROPEAN AND UNITED STATES PATIENT PERSPECTIVES ON THE IMPACT OF MODERATE TO SEVERE ULCERATIVE COLITIS ON SEXUAL ACTIVITY: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

Simon Travis Simon Travis, Eoin J. Flynn, Christian Atkinson, David T. Rubin, Stefan Schreiber, Christophe Sapin, Theresa Hunter Gibble, Cem Kayhan, Toshifumi Hibi, Remo Panaccione, Marla C. Dubinsky, Alison Potts Bleakman

NOVEL CATHETER DEDICATED FOR ENDOSCOPIC TRANSMURAL NECROSECTOMY OF PANCREATIC WALLED-OFF NECROSIS: EXPERIENCES FROM A TERTIARY REFERRAL CENTER

NOVEL CATHETER DEDICATED FOR ENDOSCOPIC TRANSMURAL NECROSECTOMY OF PANCREATIC WALLED-OFF NECROSIS: EXPERIENCES FROM A TERTIARY REFERRAL CENTER

John Gásdal Karstensen John Gásdal Karstensen, Palle Nordblad Schmidt, Erik Feldager, Srdan Novovic, Gitte Aabye Olsen

ESGE highlights with Ian Gralnek

ESGE highlights with Ian Gralnek

Ian Mark Gralnek Ian Mark Gralnek, Egle Dieninyte - Misiune

Advanced ERCP - Part 1

Advanced ERCP - Part 1

Simon Phillpotts Simon Phillpotts, George Webster, Gavin Johnson

UEG Poster
Standard Poster
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

EUROPEAN AND UNITED STATES PATIENT PERSPECTIVES ON THE IMPACT OF MODERATE TO SEVERE ULCERATIVE COLITIS ON SEXUAL ACTIVITY: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

Simon Travis 1, Alison Potts Bleakman 2, Marla C. Dubinsky 3, David T. Rubin 4, Remo Panaccione 5, Toshifumi Hibi 6, Cem Kayhan 2, Theresa Hunter Gibble 2, Christophe Sapin 2, Eoin J. Flynn 2, Christian Atkinson 7, Stefan Schreiber 8

Affiliations

1 University of Oxford, Oxford, United Kingdom

2 Eli Lilly and Company, Indianapolis, United States

3 Icahn School of Medicine, New York City, United States

4 University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, United States

5 University of Calgary, Calgary, Canada

6 Kitasato University, Tokyo, Japan

7 Adelphi Real World, Bollington, United Kingdom

8 University Hospital Schleswig-Holstein, Kiel, Germany

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Introduction

Patients with ulcerative colitis (UC) report that UC negatively affects their quality of life (QoL), including sexual functioning, satisfaction, and drive.1,2 These effects are rarely discussed with or by gastroenterologists in clinical practice. The CONFIDE study aims to elucidate the impact of symptoms on the lives of patients with moderate to severe UC in the United States (US), Europe (EU5; France, Germany, Italy, Spain, and UK), and Japan. Data presented here are from the US and EU5.

Aims & Methods

Online, quantitative, cross-sectional surveys were conducted (July–September 2021). Criteria based on previous treatment, steroid use, and/or hospitalization were used to define moderate-to-severe UC. Data collected included patient perspectives on the impact of UC on sexual activity. Sexual activity was not limited to intercourse and included activities such as masturbation.

Results

Surveys were completed by 200 US patients (male [M]=62%, mean age 40 years) and 556 EU5 patients (M=57%, mean age 39 years). Of these, 77% US and 54% EU5 patients were receiving advanced therapy (biologic/novel oral) and 52% and 73% were receiving steroids at the time of survey completion, respectively. Overall, 63% US patients (M=55%, female [F]=77%) and 53% EU5 patients (M=47%, F=60%) reported avoiding or decreasing sexual activity due to UC in the 3 months prior to the survey. Among these patients (US: N=126; EU5: N=292), most frequently reported reasons for avoidance of sexual activity were bowel urgency (BU; 41%), decreased sexual desire (37%), and fear of BU-related accidents (34%) in the US and fear of faecal seepage (37%), fear of BU-related accidents (36%), and BU itself (31%) in EU5. Although reasons for avoiding sexual activity were broadly similar between sexes, higher percentage of male patients from both US and EU5 (US: M=33%, F=24%; EU5: M=42%, F=33%) reported fear of faecal seepage as a factor affecting sexual activity. Conversely, higher percentages of female patients reported perianal pain (M=13%, F=19%) and self-consciousness (M=13%, F=24%) as reasons for avoiding sexual activity in the US and decreased sexual desire (M=16%, F=26%), BU (M=26%, F=36%) and fatigue (M=14%, F=22%) in EU5.

Conclusion

In both US and EU5 populations, >50% patients with moderate-to-severe UC reported avoiding or decreasing sexual activity due to UC, with bowel urgency and bowel urgency-related accidents being among the top three reasons. In addition to other QoL parameters, impact of UC on patients’ sexual health needs to be assessed in routine clinical practice.

References

1Bulut AE, et al. Turk J Gastroenterol. 2019;30:33-39.
2Jedel S, et al. Inflamm Bowel Dis. 2015;21:923-38.

Disclosure

Simon Travis, Grants: Ferring Pharmaceuticals, AbbVie, Schering-Plough, MSD, Procter & Gamble, Warner Chilcott, International Organization for the Study of IBD, ECCO, UCB, Vifor Pharma, Normal Collision Foundation, Buhlmann, Takeda, Janssen, Pfizer, and Eli Lilly and Company.
Marla C. Dubinsky, Consultancy fees: AbbVie, Arena Pharmaceuticals, Boehringer Ingelheim International GmbH, Bristol Myers Squibb, Celgene Corporation, Eli Lilly and Company, F. Hoffman-La Roche Ltd, Genentech Inc., Gilead Sciences, Janssen, LLC, Pfizer, Prometheus Biosciences, Takeda Pharmaceuticals USA, Inc., and UCB; Stockholder: Trellus Health Inc.; Research support: AbbVie, Janssen, LLC, Pfizer, and Prometheus Biosciences.
Toshifumi Hibi, Consultancy fees/grant/research support/speaker: AbbVie GK, ActivAid, Alfresa Pharma Corporation, Apo Plus Station, Aspen Japan K.K, Bristol-Myers Squibb, Celltrion, EA Pharma, Eli Lilly and Company, Ferring Pharmaceuticals, Gilead Sciences, Janssen, JIMRO, JMDC Inc., Kyorin, Mitsubishi-Tanabe Pharma Corporation, Mochida Pharmaceutical, Nichi-Iko Pharmaceutical, Nippon Kayaku Co. Pfizer, Takeda Pharmaceutical, Zeria Pharmaceutical, and MIYARISAN Pharmaceutical.
David T. Rubin, Grants/contracts: Takeda; Consultancy fees: AbbVie, Altrubio Inc., Allergan, Inc., American College of Gastroenterology, Arena Pharmaceuticals, Athos Therapeutics, Bellatrix Pharmaceuticals, Boehringer Ingelheim International GmbH, Bristol Myers Squibb, Celgene Corp/Syneos, Cornerstones Health, Inc. (non-profit), GalenPharma/Atlantica, Genentech/Roche, Gilead Sciences, GODURN, LLC, InDex Pharmaceuticals, Ironwood Pharmaceuticals, Iterative Scopes, Janssen, Eli Lilly and Company, Materia Prima, Pfizer, Prometheus Biosciences, Reistone Biopharma, Takeda, and Techlab Inc; Stockholder: Altrubio and Datos Health.
Remo Panaccione, Consultancy/speaker fees and/or advisory board member: AbbVie, Amgen, Arena Pharmaceuticals, Bristol-Myers Squibb, Celgene, Eli Lilly and Company, Ferring, Fresenius Kabi, Gilead Sciences, Janssen, Merck, Organon, Pfizer, Roche, Sandoz, Shire, and Takeda; Consultancy fees and/or advisory board member: Alimentiv, AstraZeneca, Biogen, Boehringer Ingelheim, Genentech, Glaxo-Smith Kline, JAMP Bio, Mylan, Novartis, Oppilan Pharma, Pandion Pharma, Progenity, Protagonist Therapeutics, Sublimity Therapeutics; Consultancy fees: Abbott, Celltrion, Cosmos Pharmaceuticals, Eisai, Elan, Galapagos, JAMP Bio, Pendopharm, Satisfai Health, Theravance Biopharma, Trellus, Viatris, and UCB.
Stefan Schreiber, Consultancy and lecture fees: AbbVie, Amgen, Arena Pharmaceuticals, Bristol Myers Squibb, Celltrion, Falk, Ferring Pharmaceuticals, Galapagos/Gilead, Genentech/Roche, Eli Lilly and Company, Janssen, MSD, Pfizer, and Takeda.
Christian Atkinson, Employee: Adelphi Real World; Consultancy: Eli Lilly and Company in connection with this study.
Alison P. Bleakman, Cem Kayhan, Theresa H. Gibble, Christophe Sapin, and Eoin J. Flynn are employees and stockholders of Eli Lilly and Company.

Conference

UEG Week Copenhagen 2023

Topics

IBD

Submission format

Abstract

Session

Disease burden of IBD (Posters)

Citation

United European Gastroenterology Journal 2023; 11 (Supplement 8)

Published

2023

More Like This:

COMPLICATIONS OF THE FIRST ENDOSONOGRAPHY-GUIDED DRAINAGE VS. FOLLOWING INTERVENTIONS IN PANCREATIC FLUID COLLECTIONS AND NECROSIS

COMPLICATIONS OF THE FIRST ENDOSONOGRAPHY-GUIDED DRAINAGE VS. FOLLOWING INTERVENTIONS IN PANCREATIC FLUID COLLECTIONS AND NECROSIS

Federica Branchi Federica Branchi, Alexander Wree, Frank Tacke, Juliane Buchkremer, Andreas Adler, Theresa Maria Holtmann, Özlem Celebi, Felix Johannes Körner, Christos Makris, Michael Sigal, Christian Jürgensen, Marcel Razpotnik

EX VIVO EFFECTS OF INFLIXIMAB ON THE LONG NON-CODING RNAS EXPRESSION LEVELS IN CROHN´S DISEASE

EX VIVO EFFECTS OF INFLIXIMAB ON THE LONG NON-CODING RNAS EXPRESSION LEVELS IN CROHN´S DISEASE

Jose Andres Moreno-Monteagudo Jose Andres Moreno-Monteagudo, Javier P. Gisbert, María Chaparro, David Bernardo, Ana M. Aransay, Urko M. Marigorta, Irene Becerro Gonzalez, Sergio Casabona-Francés, Fernando Casals Seoane, María José Casanova, Cecilio Santander Vaquero, Paloma Fernández, Ricardo Arroyo, Cristina Ramírez, Irene Soleto, Samuel Fernández-Tomé, Lorena Ortega Moreno, Macarena Orejudo del Río, Cristina Rubín de Célix, Montse Baldan Martin

EUROPEAN AND UNITED STATES PATIENT PERSPECTIVES ON THE IMPACT OF MODERATE TO SEVERE ULCERATIVE COLITIS ON SEXUAL ACTIVITY: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

EUROPEAN AND UNITED STATES PATIENT PERSPECTIVES ON THE IMPACT OF MODERATE TO SEVERE ULCERATIVE COLITIS ON SEXUAL ACTIVITY: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

Simon Travis Simon Travis, Eoin J. Flynn, Christian Atkinson, David T. Rubin, Stefan Schreiber, Christophe Sapin, Theresa Hunter Gibble, Cem Kayhan, Toshifumi Hibi, Remo Panaccione, Marla C. Dubinsky, Alison Potts Bleakman

NOVEL CATHETER DEDICATED FOR ENDOSCOPIC TRANSMURAL NECROSECTOMY OF PANCREATIC WALLED-OFF NECROSIS: EXPERIENCES FROM A TERTIARY REFERRAL CENTER

NOVEL CATHETER DEDICATED FOR ENDOSCOPIC TRANSMURAL NECROSECTOMY OF PANCREATIC WALLED-OFF NECROSIS: EXPERIENCES FROM A TERTIARY REFERRAL CENTER

John Gásdal Karstensen John Gásdal Karstensen, Palle Nordblad Schmidt, Erik Feldager, Srdan Novovic, Gitte Aabye Olsen

ESGE highlights with Ian Gralnek

ESGE highlights with Ian Gralnek

Ian Mark Gralnek Ian Mark Gralnek, Egle Dieninyte - Misiune

Advanced ERCP - Part 1

Advanced ERCP - Part 1

Simon Phillpotts Simon Phillpotts, George Webster, Gavin Johnson

UEG Poster
Standard Poster
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

NOVEL CATHETER DEDICATED FOR ENDOSCOPIC TRANSMURAL NECROSECTOMY OF PANCREATIC WALLED-OFF NECROSIS: EXPERIENCES FROM A TERTIARY REFERRAL CENTER

Gitte Aabye Olsen 1, Srdan Novovic 1,2, Erik Feldager 1, Palle Nordblad Schmidt 1, John Gásdal Karstensen 1,2

Affiliations

1 Copenhagen University Hospital Hvidovre, Hvidovre, Denmark

2 University of Copenhagen, Copenhagen, Denmark

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Introduction

The need for endoscopic necrosectomy (EN) has increased dramatically, as endoscopic EUS-guided drainage has become gold standard for treatment of pancreatic walled-off-necrosis (WON)[1,2]. Although snares and baskets are commonly used in EN procedures, they can be ineffective and dedicated instruments specifically designed for EN are scarce. Recently, an innovative powered endoscopic debridement system (EndoRotor, Interscope Inc., Northbridge, MA, USA) designed to excise and remove necrotic tissue within the WON was introduced specifically for EN with promising results[3,4]. While the first generation EndoRotor catheter was limited to 3.2 mm diameter, a larger catheter that fits into a large-channel gastroscope with a working channel of 6.0 mm has now been introduced. This study evaluates the clinical outcomes, safety, and feasibility of the novel 6.0 catheter for EN of WON.

Aims & Methods

This retrospective study was performed using prospectively collected data from all patients who underwent EN with the 6.0 catheter between December 2021 and March 2023 at Gastro Unit, Copenhagen University Hospital Hvidovre, a tertiary referral center in Denmark. All patients with symptomatic WON and need for necrosectomy were considered eligible for this study. Technical feasibility, safety, and clinical outcomes were evaluated.

Results

Sixteen patients underwent a total of 25 EN procedures with the 6.0 catheter. The mean age of the patients was 51.8 years (SD 17.7 years) and 11 (68.8%) were male. The etiology of the acute necrotizing pancreatitis was alcohol in 4 patients (25.0%), gall stones in 7 patients (43.8%), post-endoscopic retrograde cholangiopancreatography (ERCP) in 3 patients (18.8%), and idiopathic in 2 patients (12.5%). The mean size of the WON was 27.5 cm (SD 10.5 cm). The median computed tomography severity index (CTSI) was 8.5 (P25-P75: 6.0-9.0) and median modified CTSI (mCTSI) was 9.0 (P25-P75: 8.0-10). Two patients did not achieve clinical resolution (12.5%), as they died from multisystem organ failure before resolution of the WON was achieved. The median length of stay in hospital for the patients who achieved clinical resolution was 56.0 days (P25-P75: 36.5-96.0 days) and the median number of necrosectomy procedures performed to achieve clinical resolution was 5.0 (P25-P75: 2.0-8.5). All patients had EN procedures performed with snares in addition to the procedures with the powered debridement system. Five patients had necrosectomy performed with the 3.2 catheter (31.0%) as well as the 6.0 catheter. The median duration of EN with the 6.0 catheter was 60.0 minutes (P25-P75: 45.0-100 minutes) per procedure.
A device-related adverse event was noted in one instance (4.0%). The patient exhibited symptoms of peritoneal reaction in the hours following the procedure, which may have been caused by perforation of the WON into the peritoneal cavity. The patient was treated with laparoscopic peritoneal lavage and drainage and recovered without further interventions. No other procedure-related adverse events were identified. Malfunction of the catheter was observed in 7 procedures (28.0%).

Conclusion

To perform necrosectomy procedures optimally, dedicated endoscopic instruments designed for debridement of pancreatic WON are required. This study suggests that EN with the novel EndoRotor 6.0 catheter is safe and feasible with promising clinical results for EN of pancreatic WON. To assess the efficacy relative to standard techniques, comparative studies are warranted.

References

[1] Karstensen JG, Novovic S, Hansen EF, et al. EUS-guided drainage of large walled-off pancreatic necroses using plastic versus lumen-apposing metal stents: A single-centre randomised controlled trial. Gut 2022; 0: 1–7. doi:10.1136/gutjnl-2022-328225
[2] Ebrahim M, Werge MP, Hadi A, et al. Clinical outcomes following endoscopic or video-assisted retroperitoneal management of acute pancreatitis with large (>15 cm) walled-off pancreatic necrosis: Retrospective, single tertiary center cohort study. Dig Endosc 2022; 34: 1245–1252. doi:10.1111/den.14295
[3] Stassen PMC, de Jonge PJF, Bruno MJ, et al. Safety and efficacy of a novel resection system for direct endoscopic necrosectomy of walled-off pancreas necrosis: a prospective, international, multicenter trial. Gastrointest Endosc 2022; 95: 471–479. doi:10.1016/J.GIE.2021.09.025
[4] Wiel SE van der, May A, Poley JW, et al. Preliminary report on the safety and utility of a novel automated mechanical endoscopic tissue resection tool for endoscopic necrosectomy: a case series. Endosc Int Open 2020; 08: E274–E280. doi:10.1055/A-1079-5015

Conference

UEG Week Copenhagen 2023

Topics

Pancreas

Submission format

Abstract

Session

PP 08 Pancreas (Posters)

Citation

United European Gastroenterology Journal 2023; 11 (Supplement 8)

Published

2023

More Like This:

COMPLICATIONS OF THE FIRST ENDOSONOGRAPHY-GUIDED DRAINAGE VS. FOLLOWING INTERVENTIONS IN PANCREATIC FLUID COLLECTIONS AND NECROSIS

COMPLICATIONS OF THE FIRST ENDOSONOGRAPHY-GUIDED DRAINAGE VS. FOLLOWING INTERVENTIONS IN PANCREATIC FLUID COLLECTIONS AND NECROSIS

Federica Branchi Federica Branchi, Alexander Wree, Frank Tacke, Juliane Buchkremer, Andreas Adler, Theresa Maria Holtmann, Özlem Celebi, Felix Johannes Körner, Christos Makris, Michael Sigal, Christian Jürgensen, Marcel Razpotnik

EX VIVO EFFECTS OF INFLIXIMAB ON THE LONG NON-CODING RNAS EXPRESSION LEVELS IN CROHN´S DISEASE

EX VIVO EFFECTS OF INFLIXIMAB ON THE LONG NON-CODING RNAS EXPRESSION LEVELS IN CROHN´S DISEASE

Jose Andres Moreno-Monteagudo Jose Andres Moreno-Monteagudo, Javier P. Gisbert, María Chaparro, David Bernardo, Ana M. Aransay, Urko M. Marigorta, Irene Becerro Gonzalez, Sergio Casabona-Francés, Fernando Casals Seoane, María José Casanova, Cecilio Santander Vaquero, Paloma Fernández, Ricardo Arroyo, Cristina Ramírez, Irene Soleto, Samuel Fernández-Tomé, Lorena Ortega Moreno, Macarena Orejudo del Río, Cristina Rubín de Célix, Montse Baldan Martin

EUROPEAN AND UNITED STATES PATIENT PERSPECTIVES ON THE IMPACT OF MODERATE TO SEVERE ULCERATIVE COLITIS ON SEXUAL ACTIVITY: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

EUROPEAN AND UNITED STATES PATIENT PERSPECTIVES ON THE IMPACT OF MODERATE TO SEVERE ULCERATIVE COLITIS ON SEXUAL ACTIVITY: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

Simon Travis Simon Travis, Eoin J. Flynn, Christian Atkinson, David T. Rubin, Stefan Schreiber, Christophe Sapin, Theresa Hunter Gibble, Cem Kayhan, Toshifumi Hibi, Remo Panaccione, Marla C. Dubinsky, Alison Potts Bleakman

NOVEL CATHETER DEDICATED FOR ENDOSCOPIC TRANSMURAL NECROSECTOMY OF PANCREATIC WALLED-OFF NECROSIS: EXPERIENCES FROM A TERTIARY REFERRAL CENTER

NOVEL CATHETER DEDICATED FOR ENDOSCOPIC TRANSMURAL NECROSECTOMY OF PANCREATIC WALLED-OFF NECROSIS: EXPERIENCES FROM A TERTIARY REFERRAL CENTER

John Gásdal Karstensen John Gásdal Karstensen, Palle Nordblad Schmidt, Erik Feldager, Srdan Novovic, Gitte Aabye Olsen

ESGE highlights with Ian Gralnek

ESGE highlights with Ian Gralnek

Ian Mark Gralnek Ian Mark Gralnek, Egle Dieninyte - Misiune

Advanced ERCP - Part 1

Advanced ERCP - Part 1

Simon Phillpotts Simon Phillpotts, George Webster, Gavin Johnson

UEG Podcast Episode
UEG Podcast
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

ESGE highlights with Ian Gralnek

Ian Mark Gralnek, Egle Dieninyte - Misiune

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Published

2025

More Like This:

COMPLICATIONS OF THE FIRST ENDOSONOGRAPHY-GUIDED DRAINAGE VS. FOLLOWING INTERVENTIONS IN PANCREATIC FLUID COLLECTIONS AND NECROSIS

COMPLICATIONS OF THE FIRST ENDOSONOGRAPHY-GUIDED DRAINAGE VS. FOLLOWING INTERVENTIONS IN PANCREATIC FLUID COLLECTIONS AND NECROSIS

Federica Branchi Federica Branchi, Alexander Wree, Frank Tacke, Juliane Buchkremer, Andreas Adler, Theresa Maria Holtmann, Özlem Celebi, Felix Johannes Körner, Christos Makris, Michael Sigal, Christian Jürgensen, Marcel Razpotnik

EX VIVO EFFECTS OF INFLIXIMAB ON THE LONG NON-CODING RNAS EXPRESSION LEVELS IN CROHN´S DISEASE

EX VIVO EFFECTS OF INFLIXIMAB ON THE LONG NON-CODING RNAS EXPRESSION LEVELS IN CROHN´S DISEASE

Jose Andres Moreno-Monteagudo Jose Andres Moreno-Monteagudo, Javier P. Gisbert, María Chaparro, David Bernardo, Ana M. Aransay, Urko M. Marigorta, Irene Becerro Gonzalez, Sergio Casabona-Francés, Fernando Casals Seoane, María José Casanova, Cecilio Santander Vaquero, Paloma Fernández, Ricardo Arroyo, Cristina Ramírez, Irene Soleto, Samuel Fernández-Tomé, Lorena Ortega Moreno, Macarena Orejudo del Río, Cristina Rubín de Célix, Montse Baldan Martin

EUROPEAN AND UNITED STATES PATIENT PERSPECTIVES ON THE IMPACT OF MODERATE TO SEVERE ULCERATIVE COLITIS ON SEXUAL ACTIVITY: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

EUROPEAN AND UNITED STATES PATIENT PERSPECTIVES ON THE IMPACT OF MODERATE TO SEVERE ULCERATIVE COLITIS ON SEXUAL ACTIVITY: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

Simon Travis Simon Travis, Eoin J. Flynn, Christian Atkinson, David T. Rubin, Stefan Schreiber, Christophe Sapin, Theresa Hunter Gibble, Cem Kayhan, Toshifumi Hibi, Remo Panaccione, Marla C. Dubinsky, Alison Potts Bleakman

NOVEL CATHETER DEDICATED FOR ENDOSCOPIC TRANSMURAL NECROSECTOMY OF PANCREATIC WALLED-OFF NECROSIS: EXPERIENCES FROM A TERTIARY REFERRAL CENTER

NOVEL CATHETER DEDICATED FOR ENDOSCOPIC TRANSMURAL NECROSECTOMY OF PANCREATIC WALLED-OFF NECROSIS: EXPERIENCES FROM A TERTIARY REFERRAL CENTER

John Gásdal Karstensen John Gásdal Karstensen, Palle Nordblad Schmidt, Erik Feldager, Srdan Novovic, Gitte Aabye Olsen

ESGE highlights with Ian Gralnek

ESGE highlights with Ian Gralnek

Ian Mark Gralnek Ian Mark Gralnek, Egle Dieninyte - Misiune

Advanced ERCP - Part 1

Advanced ERCP - Part 1

Simon Phillpotts Simon Phillpotts, George Webster, Gavin Johnson

UEG Online Course
accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Advanced ERCP - Part 1

Gavin Johnson, George Webster, Simon Phillpotts

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Overview

Endoscopic retrograde cholangiopancreatography, or ERCP, is a procedure to diagnose and treat problems in the liver, gallbladder, bile ducts, and pancreas. After initial training, advanced techniques and approaches are necessary for an endoscopist interested in ERCP.

Both parts (four sections in each) constitute the module Advanced ERCP course (eight sections in total). Make sure to attend part I at the beginning for an introductory reminder.

The first part of this online course summarises basic ERCP and dives deeper into difficult cannulation , difficult biliary stones, cholangioscopy and biliary stricture evaluation and management.

The second part of this online course covers proximal obstruction, bile leaks, pancreatic endotherapy, EUS-guided access, aberrant anatomy and a course conclusion for both parts.

Both courses include comprehensive PPT slides and bespoke video presentations by Gavin Johnson, George Webster, and Simon Phillpotts which were filmed in London in 2022. Both parts of the combined material have a total duration of approximately 120 minutes. The estimated time needed to complete the courses, including the final assessment, is 2 hour.

Target audience

This course is suitable for gastroenterologists in training, for gastroenterologists in advanced endoscopy training or in HPB surgery, training in ERCP. It is also appropriate for endoscopy nurses and medical students who have an interest in gastroenterology.

Event

Advanced ERCP - Part 1

Topics

Endoscopy

Accreditation status

accredited

Duration

1 hour

Published

2023

More Like This:

COMPLICATIONS OF THE FIRST ENDOSONOGRAPHY-GUIDED DRAINAGE VS. FOLLOWING INTERVENTIONS IN PANCREATIC FLUID COLLECTIONS AND NECROSIS

COMPLICATIONS OF THE FIRST ENDOSONOGRAPHY-GUIDED DRAINAGE VS. FOLLOWING INTERVENTIONS IN PANCREATIC FLUID COLLECTIONS AND NECROSIS

Federica Branchi Federica Branchi, Alexander Wree, Frank Tacke, Juliane Buchkremer, Andreas Adler, Theresa Maria Holtmann, Özlem Celebi, Felix Johannes Körner, Christos Makris, Michael Sigal, Christian Jürgensen, Marcel Razpotnik

EX VIVO EFFECTS OF INFLIXIMAB ON THE LONG NON-CODING RNAS EXPRESSION LEVELS IN CROHN´S DISEASE

EX VIVO EFFECTS OF INFLIXIMAB ON THE LONG NON-CODING RNAS EXPRESSION LEVELS IN CROHN´S DISEASE

Jose Andres Moreno-Monteagudo Jose Andres Moreno-Monteagudo, Javier P. Gisbert, María Chaparro, David Bernardo, Ana M. Aransay, Urko M. Marigorta, Irene Becerro Gonzalez, Sergio Casabona-Francés, Fernando Casals Seoane, María José Casanova, Cecilio Santander Vaquero, Paloma Fernández, Ricardo Arroyo, Cristina Ramírez, Irene Soleto, Samuel Fernández-Tomé, Lorena Ortega Moreno, Macarena Orejudo del Río, Cristina Rubín de Célix, Montse Baldan Martin

EUROPEAN AND UNITED STATES PATIENT PERSPECTIVES ON THE IMPACT OF MODERATE TO SEVERE ULCERATIVE COLITIS ON SEXUAL ACTIVITY: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

EUROPEAN AND UNITED STATES PATIENT PERSPECTIVES ON THE IMPACT OF MODERATE TO SEVERE ULCERATIVE COLITIS ON SEXUAL ACTIVITY: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

Simon Travis Simon Travis, Eoin J. Flynn, Christian Atkinson, David T. Rubin, Stefan Schreiber, Christophe Sapin, Theresa Hunter Gibble, Cem Kayhan, Toshifumi Hibi, Remo Panaccione, Marla C. Dubinsky, Alison Potts Bleakman

NOVEL CATHETER DEDICATED FOR ENDOSCOPIC TRANSMURAL NECROSECTOMY OF PANCREATIC WALLED-OFF NECROSIS: EXPERIENCES FROM A TERTIARY REFERRAL CENTER

NOVEL CATHETER DEDICATED FOR ENDOSCOPIC TRANSMURAL NECROSECTOMY OF PANCREATIC WALLED-OFF NECROSIS: EXPERIENCES FROM A TERTIARY REFERRAL CENTER

John Gásdal Karstensen John Gásdal Karstensen, Palle Nordblad Schmidt, Erik Feldager, Srdan Novovic, Gitte Aabye Olsen

ESGE highlights with Ian Gralnek

ESGE highlights with Ian Gralnek

Ian Mark Gralnek Ian Mark Gralnek, Egle Dieninyte - Misiune

Advanced ERCP - Part 1

Advanced ERCP - Part 1

Simon Phillpotts Simon Phillpotts, George Webster, Gavin Johnson

The global reference point for the digestive health community

Platform Publisher

United European Gastroenterology

Wickenburggasse 1 1080 Vienna, Austria

Contact us

support@ueg.eu

ueg.eu

T: +43 1 997 1639

Legal

Terms & Conditions

Imprint

Privacy Policy

Explore

My Bookmarks

My recommendations

My fields of interest

© 2026 United European Gastroenterology

Change fields of interest

These fields are selected based on the interests in your myUEG profile.
Click the item to unselect it. You can select multiple items.